Status:
UNKNOWN
The Effect Of I-Gel And Ambu Aura-I Use On Laryngofaryngeal Mucosa
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Mucosal Damage
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
Supraglottic airway devices (SGADs) are frequently preferred in surgical surgery for pediatric patients. i-gel LMA (laryngeal mask airway) and Ambu Aura-i LMA are the new generation supraglottic airwa...
Detailed Description
This study was conducted as prospective, randomized and double-blind study. After confirmation the approval from the Interventional Ethics Committee of the Bezmialem Vakif University, dated…. Number…....
Eligibility Criteria
Inclusion
- ASA I
- patients under the age of 1,
- body weight of less than 10 kg
- without anatomical pathology in the upper airway
- no general anesthesia within the last 2 weeks who underwent minor surgery
Exclusion
- older than 1 year of age
- body weight of more than 10 kg
- symptoms of upper or lower respiratory tract infection
- more than one trial performed during the SADs placement
- known and expected to be difficult airway
- undergone surgery for more than 2 hours and patients
- underwent emergency surgery
Key Trial Info
Start Date :
May 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04062747
Start Date
May 18 2019
End Date
September 20 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakıf University
Istanbul, Fatih, Turkey (Türkiye), 34093